Subscribe Now

Subscribe Today!

Get Money Morning's top stories delivered straight to your inbox - every morning!



Money Morning Private Briefing
Private Briefing
with WILLIAM PATALON III, Executive Editor

Over a Baltimore Crab Cake Platter, Our Tech Guru Told Me About This Surging Biotech

Today marks exactly two months since we recommended Emergent BioSolutions Inc. (NYSE: EBS) – which we pitched as an “immunotherapy stock with a twist.”

In that short stretch, Emergent is up 25.5%. That’s an annualized return of 153%.

And there’s more to come…

Full Story

Today's Markets
DJIA 213.12 (1.22%) 17,706.05
NASDAQ 95.28 (2.00%) 4,861.06
S&P 28.02 (1.37%) 2,076.06